Mutation analysis of the NRXN1 gene in a Chinese autism cohort

Journal of Psychiatric Research

Volumn 46, Issue 5, 2012, Pages 630-634

  Liu, Yalan ^a   Hu, Zhengmao ^a   Xun, Guanglei ^b,c   Peng, Yu ^a   Lu, Lina ^a   Xu, Xiaojuan ^a   Xiong, Zhimin ^a   Xia, Lu ^d   Liu, Deyuan ^a   Li, Wei ^a   Zhao, Jingping ^b   Xia, Kun ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

^c SHANDONG MENTAL HEALTH CENTER   (China)

^d CENTRAL SOUTH UNIVERSITY OF FORESTRY AND TECHNOLOGY   (China)

Author keywords

Association; Autism; Mutation; Neurexin 1

Indexed keywords

NEUREXIN; NEUREXIN 1; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ALTERNATIVE RNA SPLICING; ARTICLE; AUTISM; CHILD; CHINESE; COHORT ANALYSIS; CONTROLLED STUDY; COPY NUMBER VARIATION; FEMALE; GENE DELETION; GENE EXPRESSION; GENE IDENTIFICATION; GENE MAPPING; GENE SEQUENCE; GENETIC DATABASE; GENETIC VARIABILITY; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; MUTATIONAL ANALYSIS; NUCLEOTIDE SEQUENCE; PRESCHOOL CHILD; PRIORITY JOURNAL; RISK FACTOR; SCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ASIAN CONTINENTAL ANCESTRY GROUP; AUTISTIC DISORDER; CELL ADHESION MOLECULES, NEURONAL; CHI-SQUARE DISTRIBUTION; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DNA MUTATIONAL ANALYSIS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; NERVE TISSUE PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84862811585     PISSN: 00223956     EISSN: 18791379     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2011.10.015     Document Type: Article

References (45)

1. Arac D., Boucard A.A., Ozkan E., Strop P., Newell E., Sudhof T.C., et al. Structures of neuroligin-1 and the neuroligin-1/neurexin-1 beta complex reveal specific protein-protein and protein-Ca2+ interactions. Neuron 2007, 56:992-1003.
2. Aumailley M., Smyth N. The role of laminins in basement membrane function. Journal of Anatomy 1998, 193(Pt 1):1-21.
3. Boucard A.A., Chubykin A.A., Comoletti D., Taylor P., Sudhof T.C. A splice code for trans-synaptic cell adhesion mediated by binding of neuroligin 1 to alpha- and beta-neurexins. Neuron 2005, 48:229-236.
4. Bourgeron T. A synaptic trek to autism. Current Opinion in Neurobiology 2009, 19:231-234.
5. Chao H.K., Hsiao K.J., Su T.S. A silent mutation induces exon skipping in the phenylalanine hydroxylase gene in phenylketonuria. Human Genetics 2001, 108:14-19.
6. Dale O., Salo M. The Helsinki Declaration, research guidelines and regulations: present and future editorial aspects. Acta Anaesthesiologica Scandinavica 1996, 40:771-772.
7. den Dunnen J.T., Antonarakis S.E. Mutation nomenclature extensions and suggestions to describe complex mutations: a discussion. Human Mutation 2000, 15:7-12.
8. Deng L., Yao J., Fang C., Dong N., Luscher B., Chen G. Sequential postsynaptic maturation governs the temporal order of GABAergic and glutamatergic synaptogenesis in rat embryonic cultures. Journal of Neuroscience 2007, 27:10860-10869.
9. Etherton M.R., Blaiss C.A., Powell C.M., Sudhof T.C. Mouse neurexin-1alpha deletion causes correlated electrophysiological and behavioral changes consistent with cognitive impairments. Proceedings of the National Academy of Sciences of the United States of America 2009, 106:17998-18003.
10. Feng J., Schroer R., Yan J., Song W., Yang C., Bockholt A., et al. High frequency of neurexin 1beta signal peptide structural variants in patients with autism. Neuroscience Letters 2006, 409:10-13.
11. Friedman J.M., Baross A., Delaney A.D., Ally A., Arbour L., Armstrong L., et al. Oligonucleotide microarray analysis of genomic imbalance in children with mental retardation. American Journal of Human Genetics 2006, 79:500-513.
12. Geppert M., Khvotchev M., Krasnoperov V., Goda Y., Missler M., Hammer R.E., et al. Neurexin I alpha is a major alpha-latrotoxin receptor that cooperates in alpha-latrotoxin action. Journal of Biological Chemistry 1998, 273:1705-1710.
13. Graf E.R., Zhang X., Jin S.X., Linhoff M.W., Craig A.M. Neurexins induce differentiation of GABA and glutamate postsynaptic specializations via neuroligins. Cell 2004, 119:1013-1026.
14. Hohenester E., Tisi D., Talts J.F., Timpl R. The crystal structure of a laminin G-like module reveals the molecular basis of alpha-dystroglycan binding to laminins, perlecan, and agrin. Molecular Cell 1999, 4:783-792.
15. Ichtchenko K., Nguyen T., Sudhof T.C. Structures, alternative splicing, and neurexin binding of multiple neuroligins. Journal of Biological Chemistry 1996, 271:2676-2682.
16. Ikeda M., Aleksic B., Kirov G., Kinoshita Y., Yamanouchi Y., Kitajima T., et al. Copy number variation in schizophrenia in the Japanese population. Biological Psychiatry 2010, 67:283-286.
17. Kelleher R.J., Bear M.F. The autistic neuron: troubled translation?. Cell 2008, 135:401-406.
18. Kim H.G., Kishikawa S., Higgins A.W., Seong I.S., Donovan D.J., Shen Y., et al. Disruption of neurexin 1 associated with autism spectrum disorder. American Journal of Human Genetics 2008, 82:199-207.
19. Kimchi-Sarfaty C., Oh J.M., Kim I.W., Sauna Z.E., Calcagno A.M., Ambudkar S.V., et al. A " silent" polymorphism in the MDR1 gene changes substrate specificity. Science 2007, 315:525-528.
20. Li J., Ashley J., Budnik V., Bhat M.A. Crucial role of Drosophila neurexin in proper active zone apposition to postsynaptic densities, synaptic growth, and synaptic transmission. Neuron 2007, 55:741-755.
21. Li Z., Zhang Z., He Z., Tang W., Li T., Zeng Z., et al. A partition-ligation-combination-subdivision EM algorithm for haplotype inference with multiallelic markers: update of the SHEsis (http://analysis.bio-x.cn). Cell Research 2009, 19:519-523.
22. Margolis R.L., McInnis M.G., Rosenblatt A., Ross C.A. Trinucleotide repeat expansion and neuropsychiatric disease. Archives of General Psychiatry 1999, 56:1019-1031.
23. Muhleisen T.W., Basmanav F.B., Forstner A.J., Mattheisen M., Priebe L., Herms S., et al. Resequencing and follow-up of neurexin 1 (NRXN1) in schizophrenia patients. Schizophrenia Research 2011, 127:35-40.
24. Pardo C.A., Eberhart C.G. The neurobiology of autism. Brain Pathology 2007, 17:434-447.
25. Rapin I., Tuchman R.F. What is new in autism?. Current Opinion in Neurology 2008, 21:143-149.
26. Riggins G.J., Lokey L.K., Chastain J.L., Leiner H.A., Sherman S.L., Wilkinson K.D., et al. Human genes containing polymorphic trinucleotide repeats. Nature Genetics 1992, 2:186-191.
27. Ross C.A. Intranuclear neuronal inclusions: a common pathogenic mechanism for glutamine-repeat neurodegenerative diseases?. Neuron 1997, 19:1147-1150.
28. Ross C.A., Margolis R.L., Becher M.W., Wood J.D., Engelender S., Cooper J.K., et al. Pathogenesis of neurodegenerative diseases associated with expanded glutamine repeats: new answers, new questions. Progress in Brain Research 1998, 117:397-419.
29. Ross C.A., McInnis M.G., Margolis R.L., Li S.H. Genes with triplet repeats: candidate mediators of neuropsychiatric disorders. Trends in Neurosciences 1993, 16:254-260.
30. Rowen L., Young J., Birditt B., Kaur A., Madan A., Philipps D.L., et al. Analysis of the human neurexin genes: alternative splicing and the generation of protein diversity. Genomics 2002, 79:587-597.
31. Rujescu D., Ingason A., Cichon S., Pietilainen O.P., Barnes M.R., Toulopoulou T., et al. Disruption of the neurexin 1 gene is associated with schizophrenia. Human Molecular Genetics 2009, 18:988-996.
32. Sasaki T., Billett E., Petronis A., Ying D., Parsons T., Macciardi F.M., et al. Psychosis and genes with trinucleotide repeat polymorphism. Human Genetics 1996, 97:244-246.
33. Sheckler L.R., Henry L., Sugita S., Sudhof T.C., Rudenko G. Crystal structure of the second LNS/LG domain from neurexin 1alpha: Ca2+ binding and the effects of alternative splicing. Journal of Biological Chemistry 2006, 281:22896-22905.
34. Shen K.C., Kuczynska D.A., Wu I.J., Murray B.H., Sheckler L.R., Rudenko G. Regulation of neurexin 1beta tertiary structure and ligand binding through alternative splicing. Structure 2008, 16:422-431.
35. Song J.Y., Ichtchenko K., Sudhof T.C., Brose N. Neuroligin 1 is a postsynaptic cell-adhesion molecule of excitatory synapses. Proceedings of the National Academy of Sciences of the United States of America 1999, 96:1100-1105.
36. Sugita S., Saito F., Tang J., Satz J., Campbell K., Sudhof T.C. A stoichiometric complex of neurexins and dystroglycan in brain. Journal of Cell Biology 2001, 154:435-445.
37. Szatmari P., Jones M.B., Zwaigenbaum L., MacLean J.E. Genetics of autism: overview and new directions. Journal of Autism and Developmental Disorders 1998, 28:351-368.
38. Szatmari P., Paterson A.D., Zwaigenbaum L., Roberts W., Brian J., Liu X.Q., et al. Mapping autism risk loci using genetic linkage and chromosomal rearrangements. Nature Genetics 2007, 39:319-328.
39. Tabuchi K., Sudhof T.C. Structure and evolution of neurexin genes: insight into the mechanism of alternative splicing. Genomics 2002, 79:849-859.
40. Tau G.Z., Peterson B.S. Normal development of brain circuits. Neuropsychopharmacology 2010, 35:147-168.
41. Toro R., Konyukh M., Delorme R., Leblond C., Chaste P., Fauchereau F., et al. Key role for gene dosage and synaptic homeostasis in autism spectrum disorders. Trends in Genetics 2010, 26:363-372.
42. Tryggvason K. The laminin family. Current Opinion in Cell Biology 1993, 5:877-882.
43. Ushkaryov Y.A., Petrenko A.G., Geppert M., Sudhof T.C. Neurexins: synaptic cell surface proteins related to the alpha-latrotoxin receptor and laminin. Science 1992, 257:50-56.
44. Varoqueaux F., Aramuni G., Rawson R.L., Mohrmann R., Missler M., Gottmann K., et al. Neuroligins determine synapse maturation and function. Neuron 2006, 51:741-754.
45. Waterhouse L., Morris R., Allen D., Dunn M., Fein D., Feinstein C., et al. Diagnosis and classification in autism. Journal of Autism and Developmental Disorders 1996, 26:59-86.